Literature DB >> 23060988

Extrapyramidal side effects after metoclopramide administration in a post-anesthesia care unit -A case report-.

Youn Yi Jo1, Yong Beom Kim, Mi Ran Yang, Young Jin Chang.   

Abstract

Although the incidence of extrapyramidal reactions associated with metoclopramide has been reported to be approximately 0.2%, such reactions are rare in the anesthetic field. Several anesthetic adjuvants, including ondansetron and pregabalin, have also been associated with extrapyramidal side effect. Here, the authors report the case of a 47-year-old patient, previously administered pregabalin and ondansetron, who developed extrapyramidal side effects after a single injection of metoclopramide (10 mg) in a post-anesthesia care unit.

Entities:  

Keywords:  Extrapyramidal side effect; Metoclopramide; Post-anesthesia care unit

Year:  2012        PMID: 23060988      PMCID: PMC3460160          DOI: 10.4097/kjae.2012.63.3.274

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN: 2005-6419


  12 in total

1.  Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.

Authors:  J Kamin; S Manwani; D Hughes
Journal:  Psychiatr Serv       Date:  2000-03       Impact factor: 3.084

2.  Supraglottic dystonic reaction to metoclopramide in a child.

Authors:  P A Tait
Journal:  Med J Aust       Date:  2001-06-04       Impact factor: 7.738

3.  Ondansetron-induced extrapyramidal symptoms during cesarean section.

Authors:  J E Spiegel; V Kang; L Kunze; P Hess
Journal:  Int J Obstet Anesth       Date:  2005-10       Impact factor: 2.603

4.  A case of metoclopramide-induced oculogyric crisis in a 16-year-old girl with cystic fibrosis.

Authors:  Emil Lou; Nuhad Abou-Zeid
Journal:  South Med J       Date:  2006-11       Impact factor: 0.954

5.  Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Authors:  S Kapur; R Zipursky; C Jones; G Remington; S Houle
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

6.  Pregabalin: a treatment option for dystonia?

Authors:  Christina Karosin; Markus Kofler; Andreas Mayr; Leopold Saltuari
Journal:  Neurol Sci       Date:  2011-08-18       Impact factor: 3.307

7.  Metoclopramide induced dystonia in children: two case reports.

Authors:  Uluc Yis; Durgul Ozdemir; Murat Duman; Nurettin Unal
Journal:  Eur J Emerg Med       Date:  2005-06       Impact factor: 2.799

Review 8.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 9.  Postoperative nausea and vomiting. Its etiology, treatment, and prevention.

Authors:  M F Watcha; P F White
Journal:  Anesthesiology       Date:  1992-07       Impact factor: 7.892

10.  Metoclopramide and extrapyramidal symptoms: a case report.

Authors:  Daniel D Moos; Debra J Hansen
Journal:  J Perianesth Nurs       Date:  2008-10       Impact factor: 1.084

View more
  5 in total

1.  Effect of metoclopramide administration to mothers on neonatal bilirubin and maternal prolactin: a randomized, controlled, clinical trial.

Authors:  Shirin Osouli Tabrizi; Mojgan Mirghafourvand; Abdollah Jannat Dost; Sakineh Mohammad-Alizadeh-Charandabi; Yousef Javadzadeh; Robabe Seyedi
Journal:  World J Pediatr       Date:  2018-12-05       Impact factor: 2.764

2.  Acute dystonia mimicking angioedema of the tongue: a video-illustrated case.

Authors:  Eva Rye Rasmussen; Kristine A U Pallesen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2013-07-08

3.  Metoclopramide-induced Acute Dystonia Misdiagnosed as an Epileptic Seizure in a Lupus Patient.

Authors:  Airenakho Emorinken; Oluwaseun Remi Agbadaola
Journal:  J Epilepsy Res       Date:  2021-12-31

4.  Clinical characteristics of acute drug-induced dystonia in pediatric patients.

Authors:  Hyun Woong Park; Jae Ryung Kwak; Ji Sook Lee
Journal:  Clin Exp Emerg Med       Date:  2017-09-30

5.  Safety, Pharmacokinetics, and Pharmacodynamics of Trazpiroben (TAK-906), a Novel Selective D2 /D3 Receptor Antagonist: A Phase 1 Randomized, Placebo-Controlled Single- and Multiple-Dose Escalation Study in Healthy Participants.

Authors:  Roger L Whiting; Borje Darpo; Chunlin Chen; Margaret Fletcher; Dan Combs; Hongqi Xue; Randall R Stoltz
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.